Secoo Announces Receipt of Withdrawal of Mr. Richard Rixue Li’s Going Private Proposal
May 23, 2022 07:20 ET
|
Secoo Holding Limited
BEIJING, May 23, 2022 (GLOBE NEWSWIRE) -- Secoo Holding Limited (“Secoo” or the “Company”) (NASDAQ: SECO), Asia’s leading online integrated upscale products and services platform, today announced...
Gilat Reports First Quarter 2022 Results with Strong Revenue Growth
May 23, 2022 07:06 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, May 23, 2022 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today...
The Joint Corp. Acquires Four Previously Owned Franchised Clinics, Strengthening the Scottsdale/Phoenix Region Cluster
May 23, 2022 07:05 ET
|
The Joint Corp.
SCOTTSDALE, Ariz., May 23, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, acquired four...
UCLOUDLINK GROUP INC. Announces Changes of Independent Registered Public Accounting Firm
May 23, 2022 07:02 ET
|
uCloudlink Group Inc.
HONG KONG, May 23, 2022 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“uCloudlink” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today...
TPI Composites, Inc. Appoints Ryan Miller as CFO
May 23, 2022 07:00 ET
|
TPI Composites, Inc.
SCOTTSDALE, Ariz., May 23, 2022 (GLOBE NEWSWIRE) -- TPI Composites, Inc., (TPI) (Nasdaq: TPIC), the only independent manufacturer of composite wind blades with a global footprint, announced today...
Real-World Data Analysis Reveals a Lower Risk of Tardive Dyskinesia (TD) with Metoclopramide than Previously Reported
May 23, 2022 07:00 ET
|
Evoke Pharma, Inc.
Presented as a Poster of Distinction at Digestive Disease Week (DDW) 2022, showed a 98.8 per 100,000 (0.1%) incidence of TD among gastroparesis patients treated with metoclopramide Supports Safety...
PolyPid Announces Recommendation by Data Safety Monitoring Board to Conclude Enrollment of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ at the Minimum Number of Patients Targeted Following Unblinded Interim Efficacy Analysis
May 23, 2022 07:00 ET
|
PolyPid Ltd.
• Enrollment of 950 Patients, the Minimum Number of Patients Targeted for the SHIELD I Study, Expected Within Days • Top-line Results Expected by End of Q3 2022; Potential NDA and MAA Submissions...
View Announces Earnings Date for Tuesday, May 31st, 2022
May 23, 2022 07:00 ET
|
View, Inc.
MILPITAS, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- View, Inc. (Nasdaq: VIEW) (“View” or the “Company”), the leader in smart building technologies, today announced that the Company plans to report...
Tecnoglass to Attend the B. Riley Securities 22nd Annual Institutional Investor Conference
May 23, 2022 07:00 ET
|
Tecnoglass Inc.
Barranquilla, Colombia, May 23, 2022 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NASDAQ: TGLS) ("Tecnoglass" or the "Company"), a leading manufacturer of architectural glass, windows, and associated...
COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting
May 23, 2022 07:00 ET
|
COMPASS Pathways
Positive data from phase IIb study shows potential of COMP360 psilocybin therapy in treatment-resistant depression London, UK – 23 May 2022 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a...